Merck vows to press ahead with Vioxx defense (Reuters)
12th Sep 2005, 07:20 GMT
On the eve of a second court battle over its arthritis drug Vioxx, Merck & Co. Inc. said on Friday it does not plan to enter into any global settlement of the thousands of Vioxx lawsuits it faces and is focused on "defending these cases one at a time."
Latest news from UNTITLED FEED:
- Simple steps can speed heart attack care: study (Reuters)
- Hospitals want faster heart attack care (Associated Press)
- Diabetes threatens many of world's indigenous people (Reuters)
- Fast test catches heart blockages, U.S. study shows (Reuters)
- Children showing hardening of arteries -U.S. study (Reuters)
- Children showing hardening of arteries: U.S. study (Reuters)
- Two Canada professors win right to toke up at work (Reuters)
- Results mixed on Merck's new painkiller (Associated Press)
- Group gives advice on face transplants (Associated Press)
- Diabetes drug may cut heart risks: study (Reuters)